CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 55 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,580 | -89.5% | 2,000 | -83.3% | 0.00% | – |
| Q3 2022 | $15,000 | +36.4% | 12,000 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -47.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | +16.7% | 12,000 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -25.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -36.8% | 12,000 | +9.1% | 0.00% | – |
| Q2 2021 | $38,000 | +90.0% | 11,000 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | +100.0% | 11,000 | +10.0% | 0.00% | – |
| Q4 2020 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |